Robert H. Lurie Comprehensive Cancer Center of Northwestern University is a clinical research site located in Chicago, Illinois, United States 60611.
Crixeo Clinical Trials Trust Score: 84/100 (GOOD). This profile has not yet been claimed by the site owner.
Robert H. Lurie Comprehensive Cancer Center of Northwestern University has participated in 38 clinical trials with 17 currently active.
Therapeutic areas: Triple Negative Breast Cancer, PD-L1 Positive, Advanced Cancer.
Sponsors: Gilead Sciences, Mirati Therapeutics Inc., Agenus Inc..
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Illinois · View every site in Chicago
Trust Score: 84/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Robert H. Lurie Comprehensive Cancer Center of Northwestern University has a Crixeo Trust Score of 84/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Robert H. Lurie Comprehensive Cancer Center of Northwestern University has 38 clinical trials on record, with 17 currently active. Their work covers Triple Negative Breast Cancer, PD-L1 Positive, Advanced Cancer.
Robert H. Lurie Comprehensive Cancer Center of Northwestern University has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.